FRANCE LAUNCH COMPASS · All indications · All regions · All facility types · All hub clusters · All institutions
Centres & Experts
Which centres and experts should Adaptive understand first?
All indications · All regions · All facility types · All hub clusters · All institutions
Unique HCPs
35
Clinical haematologist 20 · Biologist – flow cytometry 5 · Biologist – molecular / reference 5 · Hospital pharmacist (PUI) 5
Tier 1 KOLs
12
National / international leaders
Active trial-site participations
20
9 unique trials · Academic 11 · Industry 9
Enrolled patients
518
Across 20 trial-site records
KOL influence
35 HCPs
MRD clinical-trial portfolio
9 unique trials · 20 site participations
IFM 2020-02 (MIDAS) - MRD-Driven Consolidation/Maint in TE NDMM
MMNCT04934475 / CTIS · Phase III · IFM (Intergroupe Francophone du Myélome)
MRD-adaptive: YesNGS (10^-6) + EuroFlow NGFPrimary Endpoint (10^-6)
5 sites · 214 enrolled · Central lab: LAB-TLS-01 · CHU Toulouse (IUCT-O), LAB-LIL-01 · CHU Lille, LAB-NTE-01 · CHU Nantes
CHU Toulouse (IUCT-O) · AP-HP Saint-Louis · CHU Lille · CHU Nantes · IPC Marseille (CLCC)
FILO-CLL-MRD (ERADIC / Next-Gen uMRD Guided Therapy in CLL)
CLLNCT04639362 / CTIS · Phase II/III · FILO (French Innovative Leukemia Org)
MRD-adaptive: YesEuroFlow 8-Color NGF + NGSPrimary Endpoint (BM & PB uMRD 10^-4/10^-5)
3 sites · 94 enrolled · Central lab: LAB-PAR-01 · AP-HP Saint-Louis, LAB-LIL-01 · CHU Lille, LAB-TLS-01 · CHU Toulouse (IUCT-O)
AP-HP Saint-Louis · CHU Lille · CHU Toulouse (IUCT-O)
CARTITUDE-6 (Dara-VRd + Cilta-cel vs ASCT in NDMM)
MMNCT05243797 / CTIS · Phase III · Janssen / Legend Biotech
MRD-adaptive: NoKit-Based NGS (clonoSEQ 10^-5/10^-6)Co-Primary Endpoint (Sustained uMRD 10^-5)
2 sites · 48 enrolled · Central lab: LAB-TLS-01 · CHU Toulouse (IUCT-O), LAB-PAR-01 · AP-HP Saint-Louis
CHU Toulouse (IUCT-O) · AP-HP Saint-Louis
MajesTEC-7 (Teclistamab-Dara-Len vs DRd in TNE NDMM)
MMNCT05552222 / CTIS · Phase III · Janssen R&D
MRD-adaptive: NoNGS / EuroFlow NGFPrimary/Key Secondary (uMRD 10^-5)
2 sites · 35 enrolled · Central lab: LAB-NTE-01 · CHU Nantes, LAB-MRS-01 · IPC Marseille (CLCC)
CHU Nantes · IPC Marseille (CLCC)
MagnetisMM-7 (Elranatamab vs Len Maintenance Post-ASCT)
MMNCT05623020 / CTIS · Phase III · Pfizer
MRD-adaptive: NoKit-Based NGS (10^-5/10^-6)Primary Endpoint (uMRD 10^-5 conversion)
2 sites · 32 enrolled · Central lab: LAB-LIL-01 · CHU Lille, LAB-VJF-01 · Gustave Roussy (CLCC)
CHU Lille · Gustave Roussy (CLCC)
CELESTIAL-CLL (Sonrotoclax + Zanubrutinib Fixed-Duration L1 CLL)
CLLNCT05864210 / CTIS · Phase III · BeiGene
MRD-adaptive: NoEuroFlow NGF / ClonoSEQ NGSKey Secondary (uMRD 10^-4 / 10^-5)
2 sites · 31 enrolled · Central lab: LAB-PAR-01 · AP-HP Saint-Louis, LAB-NTE-01 · CHU Nantes
AP-HP Saint-Louis · CHU Nantes
CLL17 / FILO Collaborative (Ibr+Ven vs Ven+Obi vs Continuous Ibr)
CLLNCT05087771 / CTIS · Phase III · GCLLSG / FILO
MRD-adaptive: NoEuroFlow NGF + IgHV NGSKey Secondary (uMRD 10^-5 PB & BM)
1 site · 29 enrolled · Central lab: LAB-LYN-01 · HCL Lyon Sud
HCL Lyon Sud
IFM 2023-01 (MRD-Guided Stopping of Maintenance in MM)
MMEUCT-2023-504112 · Phase III · IFM
MRD-adaptive: YesEuroFlow NGF (10^-5) + NGSPrimary Gatekeeper (Sustained 24m uMRD)
2 sites · 20 enrolled · Central lab: LAB-NTE-01 · CHU Nantes, LAB-MRS-01 · IPC Marseille (CLCC)
CHD Vendée · CHG Avignon
BRUIN-CLL-314 / Non-Covalent BTKi + Venetoclax Time-Limited
CLLNCT05479999 / CTIS · Phase III · Eli Lilly / Loxo
MRD-adaptive: YesNGS (10^-6)Key Secondary (uMRD Rate)
1 site · 15 enrolled · Central lab: LAB-MRS-01 · IPC Marseille (CLCC)
IPC Marseille (CLCC)
Centres
Institutions with HCPs or trial sites in the sample
Centre
Facility type
16 of 16 records
| AP-HP Saint-Louis | CHU | Île-de-France | 5 | 3 | 4 | 135 | 98 |
| CHU Toulouse (IUCT-O) | CHU | Occitanie | 5 | 2 | 3 | 95 | 96 |
| CHU Lille | CHU | Hauts-de-France | 4 | 2 | 3 | 91 | 95 |
| CHU Nantes | CHU | Pays de la Loire | 4 | 2 | 3 | 72 | 94 |
| HCL Lyon Sud | CHU | Auvergne-Rhône-Alpes | 2 | 1 | 1 | 29 | 91 |
| IPC Marseille (CLCC) | CLCC | Provence-Alpes-Côte d'Azur | 4 | 1 | 3 | 62 | 89 |
| Gustave Roussy (CLCC) | CLCC | Île-de-France | 2 | 1 | 1 | 14 | 89 |
| Laboratoire Cerba (Plateau Spécialisé Cergy) | Not in institution master | Not supplied | 1 | 0 | 0 | 0 | 73 |
| CHD Vendée | CHG | Pays de la Loire | 1 | 0 | 1 | 11 | 69 |
| CHG Toulon | CHG | Provence-Alpes-Côte d'Azur | 1 | 0 | 0 | 0 | 65 |
| Clinique Pasteur | Private Clinic | Occitanie | 1 | 0 | 0 | 0 | 63 |
| CHG Avignon | CHG | Provence-Alpes-Côte d'Azur | 1 | 0 | 1 | 9 | 62 |
| CHG Albi | CHG | Occitanie | 1 | 0 | 0 | 0 | 52 |
| CHG Montauban | CHG | Occitanie | 1 | 0 | 0 | 0 | 49 |
| CHG Arras | CHG | Hauts-de-France | 1 | 0 | 0 | 0 | 48 |
| CHG Tarbes | CHG | Occitanie | 1 | 0 | 0 | 0 | 42 |
Stakeholder directory
Mapped stakeholders at covered centres
35 of 35 records
| 10007500301 | Clinical Haematologist | Service d'Immuno-Hématologie | IFM Board & Trial Chair | National Lead PI for MRD-Guided Trials | IFM, EMN, SFH | MM | 98 | Tier 1 | ||
| 10003100101 | Clinical Haematologist | Service d'Hématologie Clinique | IFM Executive Board Member | Primary Trial & Routine MRD Prescriber (MM) | IFM, SFH, EMN | MM | 96 | Tier 1 | ||
| 10007500303 | Biologist - Molecular Haematology | Labo d'Hématologie Biologique | GBMHM & EuroMRD Board | National Reference Biologist (NGS/PCR MRD) | GBMHM, EuroMRD, GRAALL, FILO | None recorded | 96 | Tier 1 | ||
| 10007500302 | Clinical Haematologist | Service d'Hématologie Seniors | FILO Executive Board | National Lead PI for FILO uMRD Trials | FILO, ERIC, SFH | CLL | 95 | Tier 1 | ||
| 10005900401 | Clinical Haematologist | Service des Maladies du Sang | IFM Vice-Chair / Board | National IFM Trial PI & Routine MRD Prescriber | IFM, SFH | MM | 95 | Tier 1 | ||
| 10003100102 | Biologist - Molecular & Cytogenetics | Labo d'Hématologie Biologique (IUCT-O) | IFM Central MRD Lab Co-Director | Central Lab Director (NGS & EuroFlow MM) | IFM, GBMHM, EuroClonality | None recorded | 94 | Tier 1 | ||
| 10004400501 | Clinical Haematologist | Service d'Hématologie Clinique | IFM Board Member | National IFM PI & Bispecific/CAR-T Lead | IFM, EMN | MM | 94 | Tier 1 | ||
| 10005900402 | Biologist - Cytometry & Molecular | Institut d'Hématologie-Transfusion | GBMHM Board Member | Central Reference Lab Director (MM & CLL MRD) | GBMHM, CytHem, EuroMRD, IFM | None recorded | 92 | Tier 1 | ||
| 10006900601 | Clinical Haematologist | Service d'Hématologie Clinique | FILO & IFM Coordinator | Regional Hub Lead Prescriber | FILO, IFM | CLL, MM & CLL | 91 | Tier 1 | ||
| 10004400502 | Biologist - Flow & Molecular | Labo d'Hématologie Biologique | IFM Central Flow Reference Lead | Directs High-Volume EuroFlow & NGS MRD Lab | CytHem, GBMHM, IFM | None recorded | 90 | Tier 1 | ||
| 10001300201 | Clinical Haematologist | Département d'Hématologie & Greffe | IFM Scientific Council | Primary MRD Prescriber (MM TE & CAR-T) | IFM, SFGM-TC | MM | 89 | Tier 1 | ||
| 10009400701 | Clinical Haematologist | DITEP / Hématologie | IFM Phase I/II Lead | Trial & Routine MRD Prescriber | IFM, Unicancer | MM | 89 | Tier 1 | ||
| 10006900602 | Biologist - Molecular & Flow | Centre de Biologie Sud | GBMHM Committee | Directs HCL MRD Platform | GBMHM, CytHem | None recorded | 86 | Tier 2 | ||
| 10005900403 | Clinical Haematologist | Service des Maladies du Sang | FILO Scientific Committee | Lead CLL Prescriber & FILO Investigator | FILO, ERIC | CLL | 84 | Tier 2 | ||
| 10007500304 | Biologist - Flow Cytometry | Unité de Cytométrie Hématologique | CytHem Reference Lead | Lead Cytometrist for Routine MM/CLL MRD | CytHem, EuroFlow | None recorded | 83 | Tier 2 | ||
| 10003100103 | Clinical Haematologist | Service d'Hématologie Clinique | FILO CLL Working Group | Routine & Trial MRD Prescriber (CLL) | FILO, SFH | CLL | 81 | Tier 2 | ||
| 10001300202 | Biologist - Molecular Biology | Plateforme de Biopathologie Moléculaire | GBMHM Active Member | Heads NGS & Flow MRD Execution | GBMHM, Unicancer | None recorded | 79 | Tier 2 | ||
| 10003100104 | Biologist - Flow Cytometry | Plateau de Cytométrie en Flux | CytHem Scientific Committee | Executes Routine NGF MRD (MM & CLL) | CytHem, EuroFlow, IFM | None recorded | 78 | Tier 2 | ||
| 10009400702 | Biologist - Molecular Genetics | Département de Biologie et Pathologie | Member | Supervises NGS MRD Workflows | GBMHM, Unicancer | None recorded | 77 | Tier 2 | ||
| 10007500305 | Hospital Pharmacist (PUI) | PUI Hôpital Saint-Louis | AP-HP Cell Therapy Committee | Manages CAR-T & Bispecific Pharmacy Governance | SFPO, AP-HP AGEPS | None recorded | 76 | Tier 2 | ||
| 10004400503 | Clinical Haematologist | Service d'Hématologie Clinique | FILO Active Investigator | Orders Routine & Trial CLL MRD | FILO | CLL | 75 | Tier 2 | ||
| 10001300203 | Clinical Haematologist | Département d'Hématologie | FILO Investigator | Orders CLL Fixed-Duration End-of-Trt MRD | FILO, LYSA | CLL | 74 | Tier 2 | ||
| 10009501601 | Biologist - Specialty Reference Lab | Département Hématologie Spécialisée | Private Reference Lab Lead | Executes Subcontracted NGS/Flow MRD for Clinics/CHGs | GBMHM, CytHem | None recorded | 73 | Tier 2 | ||
| 10008501501 | Clinical Haematologist | Service d'Hématologie | Active Investigator | High-Volume Spoke Ordering MRD via CHU Nantes | IFM, FILO | MM | 69 | Tier 2 | ||
| 10008301301 | Clinical Haematologist | Service d'Hématologie | Active Investigator | Ships MRD Samples to IPC Marseille | IFM, FILO | MM | 65 | Tier 3 | ||
| 10003100105 | Hospital Pharmacist (PUI) | Pharmacie à Usage Intérieur (PUI) | Regional ARS Liste en Sus Reviewer | Manages CAR-T/Bispecific & RIHN Budget | SFPO | None recorded | 64 | Tier 3 | ||
| 10003101101 | Clinical Haematologist | Institut de Cancérologie Pasteur | Active Private Investigator | Sends Out MRD to Cerba & CHU Toulouse | IFM, FILO | MM | 63 | Tier 3 | ||
| 10008401201 | Clinical Haematologist | Service d'Hématologie Clinique | Active Investigator | Ships MRD Samples to IPC Marseille | IFM, FILO | MM | 62 | Tier 3 | ||
| 10004400504 | Hospital Pharmacist (PUI) | PUI Hôtel-Dieu | Member | PUI Oncology Pharmacist | SFPO | None recorded | 60 | Tier 3 | ||
| 10001300204 | Hospital Pharmacist (PUI) | Pharmacie Centrale IPC | Unicancer Pharmacy Network | Oversees Accès Précoce & Liste en Sus | SFPO, Unicancer | None recorded | 58 | Tier 3 | ||
| 10005900404 | Hospital Pharmacist (PUI) | Pharmacie Centrale CHU Lille | Member | Hospital Drug & Diagnostic Budget Liaison | SFPO | None recorded | 56 | Tier 3 | ||
| 10008100801 | Clinical Haematologist | Service d'Oncologie-Hématologie | Regional Network Investigator | Ships Bone Marrow Samples to CHU Toulouse | IFM, FILO | MM, CLL | 52 | Tier 3 | ||
| 10008200901 | Clinical Haematologist | Hôpital de Jour Hématologie | Regional Network Member | Ships Bone Marrow Samples to CHU Toulouse | IFM | MM | 49 | Tier 3 | ||
| 10006201401 | Clinical Haematologist | Hématologie Clinique | Member | Ships MRD Samples to CHU Lille | IFM | MM | 48 | Tier 3 | ||
| 10006501001 | Clinical Haematologist | Service de Médecine Interne / Hémato | Member | Refers TE-MM & Ships MRD to CHU Toulouse | SFH | MM | 42 | Tier 3 |